Pharmaceutical company Zydus Cadila on Monday said that the Indian government has ordered one crore doses of ZyCoV-D vaccine against the coronavirus.
The ZyCov-D is the world’s first DNA vaccine against the coronavirus disease and is given in three doses. It makes use of a portion of the genetic code – deoxyribonucleic acid or ribonucleic acid – in the SARS-CoV-2 virus to stimulate an immune response against its spike protein, according to the Ahmedabad-headquartered company.
The vaccine was approved by the Drug Controller General of India on August 20 for emergency use in adults and children aged 12 years and above.
In a filing to the stock exchanges on Monday, Zydus Cadila said it has set a price of Rs 265 per dose. The price was decided in consultation with the government.
However, the vaccine’s needle-free applicator, called the Pharmajet, will be sold separately at Rs 93, excluding the goods and services tax. Pharmajet is devised to ensure painless delivery of the vaccine through the skin.
With this, the total cost of the vaccine will be Rs 358 per dose. Earlier, the company had proposed a cost of Rs 1,900 with taxes for every dose of the ZyCoV-D vaccine.
Meanwhile, the government is yet to receive suggestions from National Technical Advisory Group on Immunisation on introducing ZyCoV-D in…